Flumethasone + salicylic acid (cutaneous)
Generic name
Flumethasone + salicylic acid (cutaneous)
Brand name
ATC Code
D07XB01
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
Very limited resorption (flumethasone, salicylic acid). However, in extensive and repeated use, combining it with salicylic acid may result in the resorption of flumethasone to such an extent that systemic side effects occur.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Psoriasis, lichen ruber, lichen sclerosus and atrophicus, annular granuloma, palmoplantar pustulosis, contact dermatitis and chronic lichen simplex |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
Children are particularly sensitive to corticosteroids; systemic side effects in particular occur more quickly due to their thinner skin and relatively large skin surface area.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Use with caution in children and patients with hepatic and/or renal impairment because of the elevated risk of systemic side effects; there is also an increased risk of salicylism in children and patients with severe renal impairment. Use in children can rapidly cause adrenal cortex suppression and also growth hormone suppression; in the event of prolonged use, regular checks on height and weight and determination of plasma cortisol levels are recommended.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
CORTICOSTEROIDS, OTHER COMBINATIONS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Corticosteroids, moderately potent, other combinations | ||
|---|---|---|
| D07XB02 | ||
Reference
- Amdipharm Limited, SmPC Locasalen (RVG 05901) 30-04-2018, www.geneesmiddeleninformatiebank.nl
Changes
Therapeutic Drug Monitoring
Overdose
